Biblio
A Discussion with Dr. Natasha Kekre, Hematologist and Clinician Scientist. Clin Invest Med. 2024;47(1):1-3.
. Acquired hemophilia A following allogeneic stem cell transplantation for acute lymphoblastic leukemia. Ann Hematol. 2022.
. The optimal timing of allogeneic stem cell transplantation for primary myelofibrosis. Transplant Cell Ther. 2022.
. Efficacy, Safety, and Practicality of Tacrolimus Monitoring after Bone Marrow Transplant: Assessment of a Change in Practice. Can J Hosp Pharm. 2020;73(1):37-44.
. Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate, but not High Disease Risk Index: A CIBMTR Study: Superior DFS with MAC comp. Biol Blood Marrow Transplant. 2020.
Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020;4(13):3180-3190.
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia. Blood Adv. 2019;3(20):3123-3131.
Effect of donor age and donor relatedness on time to allogeneic hematopoietic cell transplantation in acute leukemia. Biol Blood Marrow Transplant. 2018.